Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in China, is the cause of the global pandemic Coronavirus Disease 19 (Covid-19). To date, there is no widely available vaccine or treatment, hence containment strategies are currently centred around measures ameliorating human transmission via social distancing and quarantine. Due to the magnitude of the pandemic, elective operative work had ceased within cardiac surgery at our institution and strategies adapted to facilitate safe management of surgical candidates. Here, we present the case report of an asymptomatic inpatient with prolonged viral shedding on real-time polymerase chain reaction (RT-PCR) on oropharyngeal swabs who required urgent coronary artery revascularisation, and the lessons learnt from the adapted management strategy deployed for revascularisation during the COVID-19 pandemic.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in China, is the cause of the global pandemic Coronavirus Disease 19 (Covid-19). To date, there is no widely available vaccine or treatment, hence containment strategies are currently centred around measures ameliorating human transmission via social distancing and quarantine. Due to the magnitude of the pandemic, elective operative work had been halted within cardiac surgery at our institution and protocols adapted to facilitate safe operating and discharge of surgical patients. With rapidly emerging data on the characteristics of SARS-CoV-2, we present 2 in-patient cases at our institution with prolonged viral shedding detected on real-time polymerase chain reaction (RT-PCR) oropharyngeal swabs; one asymptomatic, and another pauci-symptomatic. These cases highlight the need for further research into the duration of viral shedding and the viability of SARS-CoV-2, especially with respect to viral transmission, over a drawn-out period.